tiprankstipranks
Scinai Immunotherapeutics (SCNI)
NASDAQ:SCNI
US Market
SCNI
Scinai Immunotherapeutics
RESEARCH TOOLSreports

Scinai Immunotherapeutics (SCNI) Financial Statements

335 Followers

Scinai Immunotherapeutics Financial Overview

Scinai Immunotherapeutics's market cap is currently $2.05M. The company's EPS TTM is $-4.742; its P/E ratio is ―; Scinai Immunotherapeutics is scheduled to report earnings on December 2, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Mar 23Dec 21
Income Statement
Total Revenue$ 1.31M$ 658.00K$ 0.00$ 0.00$ 0.00
Gross Profit$ -2.65M$ -580.00K$ -512.67K$ -559.80K$ -747.65K
Operating Income$ -7.54M$ -8.64M$ -9.71M$ -11.06M$ -10.87M
EBITDA$ -6.53M$ -6.99M$ -9.19M$ -10.50M$ -10.39M
Net Income$ -8.31M$ 4.80M$ -6.50M$ -5.80M$ -8.21M
Balance Sheet
Cash & Short-Term Investments$ 1.66M$ 1.96M$ 4.87M$ 14.07M$ 17.37M
Total Assets$ 11.63M$ 13.45M$ 17.47M$ 27.07M$ 32.04M
Total Debt$ 2.27M$ 2.09M$ 20.56M$ 21.54M$ 29.23M
Net Debt$ 606.00K$ 122.00K$ 15.69M$ 7.47M$ 11.86M
Total Liabilities$ 3.52M$ 3.47M$ 22.04M$ 28.83M$ 31.05M
Stockholders' Equity$ 8.10M$ 9.98M$ -4.57M$ -1.76M$ 982.00K
Cash Flow
Free Cash Flow$ -6.05M$ -6.35M$ -10.02M$ -8.10M$ -7.57M
Operating Cash Flow$ -6.03M$ -6.33M$ -9.38M$ -7.26M$ -7.43M
Investing Cash Flow$ -24.00K$ -12.00K$ -637.00K$ -836.00K$ -139.00K
Financing Cash Flow$ 5.77M$ 3.44M$ 1.09M$ 6.78M$ 21.43M
Currency in USD

Scinai Immunotherapeutics Earnings and Revenue History

Income Statement >

Scinai Immunotherapeutics Debt to Assets

Balance Sheet >

Scinai Immunotherapeutics Cash Flow

Cash Flow >

Scinai Immunotherapeutics Forecast EPS vs Actual EPS

Earnings >